Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-05

Clinical Trial Update: Medical Dissolution of Cholesterol Gallstones Using Oral Aramchol - A Proof of Concept Phase IIa Study [Phase 2]

View source ↗

Summary

A Phase IIa proof-of-concept study evaluating Aramchol for dissolution of cholesterol gallstones was terminated. The update notes the termination without report…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aramchol

Snippet

Sponsor: Galmed Pharmaceuticals Ltd | Conditions: Gallstones | Phase 2 | Status: TERMINATED